- Home
- HOUR vs VERU Comparison
HOUR vs VERU Comparison
Compare HOUR & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOUR
- VERU
- Stock Information
- Founded
- HOUR 2015
- VERU 1971
- Country
- HOUR United States
- VERU United States
- Employees
- HOUR N/A
- VERU N/A
- Industry
- HOUR Catalog/Specialty Distribution
- VERU Biotechnology: Pharmaceutical Preparations
- Sector
- HOUR Consumer Discretionary
- VERU Health Care
- Exchange
- HOUR Nasdaq
- VERU Nasdaq
- Market Cap
- HOUR 63.3M
- VERU 54.6M
- IPO Year
- HOUR 2022
- VERU 1990
- Fundamental
- Price
- HOUR $2.77
- VERU $4.29
- Analyst Decision
- HOUR
- VERU Strong Buy
- Analyst Count
- HOUR 0
- VERU 3
- Target Price
- HOUR N/A
- VERU $33.33
- AVG Volume (30 Days)
- HOUR 399.0K
- VERU 158.4K
- Earning Date
- HOUR 11-11-2025
- VERU 08-12-2025
- Dividend Yield
- HOUR N/A
- VERU N/A
- EPS Growth
- HOUR N/A
- VERU N/A
- EPS
- HOUR 0.02
- VERU N/A
- Revenue
- HOUR $138,441,228.00
- VERU $16,886,419.00
- Revenue This Year
- HOUR N/A
- VERU N/A
- Revenue Next Year
- HOUR N/A
- VERU N/A
- P/E Ratio
- HOUR $128.51
- VERU N/A
- Revenue Growth
- HOUR N/A
- VERU 337.24
- 52 Week Low
- HOUR $1.10
- VERU $2.64
- 52 Week High
- HOUR $6.90
- VERU $14.20
- Technical
- Relative Strength Index (RSI)
- HOUR 49.74
- VERU 74.55
- Support Level
- HOUR $2.71
- VERU $3.75
- Resistance Level
- HOUR $2.94
- VERU $3.99
- Average True Range (ATR)
- HOUR 0.26
- VERU 0.24
- MACD
- HOUR -0.08
- VERU -0.01
- Stochastic Oscillator
- HOUR 15.11
- VERU 94.34
About HOUR Hour Loop Inc.
Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.